•
Jun 30, 2024

Westlake Q2 2024 Earnings Report

Westlake reported strong demand for HIP segment products and higher PEM segment average sales price, leading to year-over-year quarterly earnings growth.

Key Takeaways

Westlake Corporation reported Q2 2024 results with net sales of $3.2 billion, net income of $313 million, and EBITDA of $744 million. The company saw record Housing and Infrastructure Products (HIP) segment income from operations of $266 million and EBITDA of $336 million. There were sequential increases in Performance and Essential Materials (PEM) segment earnings and margins.

Record Housing and Infrastructure Products (HIP) segment income from operations of $266 million.

Record HIP segment EBITDA of $336 million.

Sequential increases in Performance and Essential Materials (PEM) segment earnings and margins.

Overall sales volume increased 6% sequentially from the previous quarter.

Total Revenue
$3.21B
Previous year: $3.25B
-1.4%
EPS
$2.4
Previous year: $2.31
+3.9%
Gross Profit
$634M
Previous year: $642M
-1.2%
Cash and Equivalents
$3.04B
Previous year: $2.68B
+13.6%
Free Cash Flow
$6M
Previous year: $315M
-98.1%
Total Assets
$21.1B
Previous year: $21B
+0.5%

Westlake

Westlake

Forward Guidance

Conditions in the HIP segment should continue to be supported by favorable structural factors. Steps are being taken to enhance PEM segment profitability, including a plan to temporarily cease operations at two units within the European epoxy business.

Positive Outlook

  • Favorable structural factors supporting conditions in the HIP segment.
  • Decade-long under-investment in housing.
  • Population growth.
  • Aging housing stock.
  • Increasing investments in infrastructure driven by the Infrastructure and Jobs Act.

Challenges Ahead

  • Global industrial and manufacturing activity remains sluggish.
  • Plan to temporarily cease operations at two units within our European epoxy business.
  • Uncertainties associated with political tensions and conflict in the Middle East, Russia and Ukraine and elsewhere
  • Uncertainties associated with pandemic infectious diseases
  • Uncertainties associated with climate change